Literature DB >> 12663806

Human herpesvirus 6 variant A glycoprotein H-glycoprotein L-glycoprotein Q complex associates with human CD46.

Yasuko Mori1, Xuwei Yang, Pilailuk Akkapaiboon, Toshiomi Okuno, Koichi Yamanishi.   

Abstract

Human CD46 is a cellular receptor for human herpesvirus 6 (HHV-6). Virus entry into host cells requires a glycoprotein H (gH)-glycoprotein L (gL) complex. We show that the CD46 ectodomain blocked HHV-6 infection and bound a complex of gH-gL and the 80-kDa U100 gene product, designated glycoprotein Q, indicating that the complex is a viral ligand for CD46.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12663806      PMCID： PMC152135          DOI： 10.1128/jvi.77.8.4992-4999.2003

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  40 in total

1.  Pseudorabies virus glycoprotein L is necessary for virus infectivity but dispensable for virion localization of glycoprotein H.

Authors:  B G Klupp; W Fuchs; E Weiland; T C Mettenleiter
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells.

Authors:  Q Li; S M Turk; L M Hutt-Fletcher
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

3.  Epstein-Barr virus lacking glycoprotein gp42 can bind to B cells but is not able to infect.

Authors:  X Wang; L M Hutt-Fletcher
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

4.  Identification of a variant B-specific neutralizing epitope on glycoprotein H of human herpesvirus-6.

Authors:  K Takeda; M Haque; T Sunagawa; T Okuno; Y Isegawa; K Yamanishi
Journal:  J Gen Virol       Date:  1997-09       Impact factor: 3.891

5.  The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation.

Authors:  M K Spriggs; R J Armitage; M R Comeau; L Strockbine; T Farrah; B Macduff; D Ulrich; M R Alderson; J Müllberg; J I Cohen
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

6.  Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes.

Authors:  Q Li; M K Spriggs; S Kovats; S M Turk; M R Comeau; B Nepom; L M Hutt-Fletcher
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

7.  Glycoprotein H (gII/gp108) and glycoprotein L form a functional complex which plays a role in penetration, but not in attachment, of bovine herpesvirus 1.

Authors:  S van Drunen Littel-van den Hurk; S Khattar; S K Tikoo; L A Babiuk; E Baranowski; D Plainchamp; E Thiry
Journal:  J Gen Virol       Date:  1996-07       Impact factor: 3.891

8.  Variability of herpes simplex virus 1 gL and anti-gL antibodies that inhibit cell fusion but not viral infectivity.

Authors:  M J Novotny; M L Parish; P G Spear
Journal:  Virology       Date:  1996-07-01       Impact factor: 3.616

9.  Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46.

Authors:  K Iwata; T Seya; Y Yanagi; J M Pesando; P M Johnson; M Okabe; S Ueda; H Ariga; S Nagasawa
Journal:  J Biol Chem       Date:  1995-06-23       Impact factor: 5.157

10.  Glycoprotein gH of pseudorabies virus is essential for penetration and propagation in cell culture and in the nervous system of mice.

Authors:  N Babic; B G Klupp; B Makoschey; A Karger; A Flamand; T C Mettenleiter
Journal:  J Gen Virol       Date:  1996-09       Impact factor: 3.891
View more
  36 in total

1.  Analysis of a neutralizing antibody for human herpesvirus 6B reveals a role for glycoprotein Q1 in viral entry.

Authors:  Akiko Kawabata; Hiroko Oyaizu; Takahiro Maeki; Huamin Tang; Koichi Yamanishi; Yasuko Mori
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

2.  Induction of cell-cell fusion from without by human herpesvirus 6B.

Authors:  Simon Metz Pedersen; Bodil Oster; Bettina Bundgaard; Per Höllsberg
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

3.  Characterization of human cytomegalovirus glycoprotein-induced cell-cell fusion.

Authors:  Eric R Kinzler; Teresa Compton
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

4.  Localization of regions in CD46 that interact with adenovirus.

Authors:  Anuj Gaggar; Dmitry M Shayakhmetov; M Kathryn Liszewski; John P Atkinson; André Lieber
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

Review 5.  Herpesvirus entry: an update.

Authors:  Patricia G Spear; Richard Longnecker
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 6.  Emerging roles and new functions of CD46.

Authors:  M Kathryn Liszewski; Claudia Kemper; Jeffrey D Price; John P Atkinson
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

7.  Detailed study of the interaction between human herpesvirus 6B glycoprotein complex and its cellular receptor, human CD134.

Authors:  Huamin Tang; Junjie Wang; Nora F Mahmoud; Yasuko Mori
Journal:  J Virol       Date:  2014-07-09       Impact factor: 5.103

8.  Intracellular processing of human herpesvirus 6 glycoproteins Q1 and Q2 into tetrameric complexes expressed on the viral envelope.

Authors:  Pilailuk Akkapaiboon; Yasuko Mori; Tomohiko Sadaoka; Sayoko Yonemoto; Koichi Yamanishi
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

9.  Discovery of a second form of tripartite complex containing gH-gL of human herpesvirus 6 and observations on CD46.

Authors:  Yasuko Mori; Pilailuk Akkapaiboon; Sayoko Yonemoto; Masato Koike; Masaya Takemoto; Tomohiko Sadaoka; Yumi Sasamoto; Shozo Konishi; Yasuo Uchiyama; Koichi Yamanishi
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 10.  Classification of HHV-6A and HHV-6B as distinct viruses.

Authors:  Dharam Ablashi; Henri Agut; Roberto Alvarez-Lafuente; Duncan A Clark; Stephen Dewhurst; Dario DiLuca; Louis Flamand; Niza Frenkel; Robert Gallo; Ursula A Gompels; Per Höllsberg; Steven Jacobson; Mario Luppi; Paolo Lusso; Mauro Malnati; Peter Medveczky; Yasuko Mori; Philip E Pellett; Joshua C Pritchett; Koichi Yamanishi; Tetsushi Yoshikawa
Journal:  Arch Virol       Date:  2013-11-06       Impact factor: 2.574
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.